I. Bureau

489 total citations
25 papers, 338 citations indexed

About

I. Bureau is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Nutrition and Dietetics. According to data from OpenAlex, I. Bureau has authored 25 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Epidemiology and 4 papers in Nutrition and Dietetics. Recurrent topics in I. Bureau's work include Trace Elements in Health (4 papers), Diabetes Management and Research (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). I. Bureau is often cited by papers focused on Trace Elements in Health (4 papers), Diabetes Management and Research (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). I. Bureau collaborates with scholars based in France and United States. I. Bureau's co-authors include J. Gourmelen, Anne‐Marie Roussel, S. Bouée, Alain Favier, Charles G. Lewis, Richard A. Anderson, Meira Fields, Josiane Arnaud, B. Detournay and Edmond Rock and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Clinical Chemistry.

In The Last Decade

I. Bureau

24 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Bureau France 11 83 72 58 54 48 25 338
M. André France 11 81 1.0× 30 0.4× 42 0.7× 87 1.6× 58 1.2× 46 394
Pedro Henrique França Gois Australia 10 80 1.0× 26 0.4× 25 0.4× 37 0.7× 23 0.5× 24 454
Caitlin J. Smith United States 10 46 0.6× 37 0.5× 43 0.7× 75 1.4× 23 0.5× 15 596
Vinod Nookala United States 9 51 0.6× 17 0.2× 34 0.6× 38 0.7× 27 0.6× 39 309
Geeta Sharma United States 13 55 0.7× 18 0.3× 38 0.7× 24 0.4× 76 1.6× 48 463
Seyedeh Mahdieh Namayandeh Iran 12 42 0.5× 113 1.6× 50 0.9× 94 1.7× 15 0.3× 57 487
Philippe Bianga Katchunga Democratic Republic of the Congo 11 42 0.5× 108 1.5× 29 0.5× 88 1.6× 12 0.3× 40 374
Shani Botha South Africa 11 42 0.5× 45 0.6× 38 0.7× 43 0.8× 11 0.2× 19 379
Katariina Kallio Finland 15 81 1.0× 90 1.3× 211 3.6× 109 2.0× 87 1.8× 23 908

Countries citing papers authored by I. Bureau

Since Specialization
Citations

This map shows the geographic impact of I. Bureau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Bureau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Bureau more than expected).

Fields of papers citing papers by I. Bureau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Bureau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Bureau. The network helps show where I. Bureau may publish in the future.

Co-authorship network of co-authors of I. Bureau

This figure shows the co-authorship network connecting the top 25 collaborators of I. Bureau. A scholar is included among the top collaborators of I. Bureau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Bureau. I. Bureau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arnaud, Laurent, et al.. (2025). Real-world oral glucocorticoid use in SLE: a nation-wide population-based study using the French medico-administrative (SNDS) claim database. Lupus Science & Medicine. 12(1). e001428–e001428. 1 indexed citations
2.
Gourdy, Pierre, Patrice Darmon, Isabelle Borget, et al.. (2024). Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study. Diabetes Therapy. 15(6). 1349–1360.
4.
Loubet, Paul, Jérôme Fernandes, Gérard de Pouvourville, et al.. (2023). Respiratory syncytial virus-related hospital stays in adults in France from 2012 to 2021: A national hospital database study. Journal of Clinical Virology. 171. 105635–105635. 17 indexed citations
5.
Gourmelen, J., et al.. (2020). Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France. PLoS ONE. 15(12). e0243529–e0243529. 47 indexed citations
6.
Weil-Olivier, Catherine, Muhamed‐Kheir Taha, Corinne Emery, et al.. (2019). PIN105 DESCRIPTION OF PATIENTS HOSPITALIZED WITH MENINGOCOCCAL INFECTIONS IN FRANCE: AN ANALYSIS OF THE NATIONAL HEALTHCARE CLAIM(SNIIR-AM) DATABASE. Value in Health. 22. S656–S656. 1 indexed citations
7.
Bourdin, Arnaud, J. Ostinelli, S. Bouée, et al.. (2019). The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database. The Journal of Allergy and Clinical Immunology In Practice. 7(5). 1477–1487. 39 indexed citations
8.
Dallongeville, Jean, Frédéric Sacher, S. Bouée, et al.. (2018). Xafran, a drug utilization study of rivaroxaban in stroke prevention in atrial fibrillation in France using a claim database. Therapies. 73(6). 449–460. 2 indexed citations
11.
Charbonnel, B, Dominique Simon, Jean Dallongeville, et al.. (2017). Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis. PharmacoEconomics - Open. 2(2). 209–219. 32 indexed citations
12.
Magne, Isabelle, et al.. (2016). Exposure of children to extremely low frequency magnetic fields in France: Results of the EXPERS study. Journal of Exposure Science & Environmental Epidemiology. 27(5). 505–512. 12 indexed citations
13.
Simon, D., Jean Dallongeville, B Charbonnel, et al.. (2015). Patterns of Pharmacological Treatment in Type 2 Diabetes in France in 2013. Value in Health. 18(7). A599–A599. 3 indexed citations
14.
Thiébaut, Anne, et al.. (2014). Allogeneic Stem Cell Transplant With Graft Versus Host Disease In France In 2012 Based On National Hospital Databases (Pmsi). Value in Health. 17(7). A524–A524. 1 indexed citations
15.
Bureau, I., Elyett Gueux, Andrzej Mazur, et al.. (2003). Female Rats Are Protected against Oxidative Stress during Copper Deficiency. Journal of the American College of Nutrition. 22(3). 239–246. 38 indexed citations
16.
Bureau, I., et al.. (2002). Trace mineral status in post menopausal women: impact of hormonal replacement therapy. Journal of Trace Elements in Medicine and Biology. 16(1). 9–13. 55 indexed citations
18.
Bureau, I., François Laporte, Henri Faure, et al.. (2002). No Antioxidant Effect of Combined HRT on LDL Oxidizability and Oxidative Stress Biomarkers in Treated Post-Menopausal Women. Journal of the American College of Nutrition. 21(4). 333–338. 21 indexed citations
19.
Lewis, Charles G., et al.. (2001). Aspirin reduces blood cholesterol in copper-deficient rats: A potential antioxidant agent?. Metabolism. 50(5). 558–561. 13 indexed citations
20.
Bureau, I., Charles G. Lewis, & Meira Fields. (1998). Effect of Hepatic Iron on Hypercholesterolemia and Hypertriacylglycerolemia in Copper-Deficient Fructose-Fed Rats. Nutrition. 14(4). 366–371. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026